Patents by Inventor Ranjan Dohil

Ranjan Dohil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
    Patent number: 10307386
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: June 4, 2019
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
    Patent number: 10272037
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: April 30, 2019
    Assignees: The Regents of the University of California, Meritage Pharma, Inc.
    Inventors: Ranjan Dohil, John Bastian, Seema Aceves, Elaine Phillips, Malcolm Hill
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20190060264
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: March 15, 2018
    Publication date: February 28, 2019
    Inventors: Ranjan Dohil, Jerry Schneider
  • METHODS OF TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) USING CYSTEAMINE COMPOUNDS
    Publication number: 20180338928
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine or cystamine compositions. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: November 16, 2016
    Publication date: November 29, 2018
    Inventors: Ranjan Dohil, Patrice Rioux
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9925156
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: March 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9925157
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: March 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9925158
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: March 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • TOPICAL CORTICOSTEROIDS FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT
    Publication number: 20180071211
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Application
    Filed: September 18, 2017
    Publication date: March 15, 2018
    Inventors: Ranjan Dohil, John Bastian, Seema Aceves, Elaine Phillips, Malcolm Hill
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9814689
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: November 14, 2017
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20170319524
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20170319522
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20170319523
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • METHODS OF TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) USING CYSTEAMINE PRODUCTS
    Publication number: 20170304233
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: November 28, 2016
    Publication date: October 26, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9795578
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: October 24, 2017
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
    Patent number: 9782347
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Grant
    Filed: January 3, 2014
    Date of Patent: October 10, 2017
    Assignees: The Regents of the University of California, Meritage Pharma, Inc.
    Inventors: Ranjan Dohil, John Bastian, Seema Aceves, Elaine Phillips, Malcolm Hill
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9750708
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: September 5, 2017
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20170042845
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: October 27, 2016
    Publication date: February 16, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9511039
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: December 6, 2016
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
    Patent number: 9511038
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Grant
    Filed: September 28, 2015
    Date of Patent: December 6, 2016
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20160331691
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 29, 2016
    Publication date: November 17, 2016
    Inventors: Ranjan Dohil, Jerry Schneider